Skip to main content
. 2021 Jan 29;44(7):1379–1386. doi: 10.1007/s40618-021-01515-6

Table 1.

Clinical characteristics of trials included in the review

Author Type of study Location(s) Subjects with diabetes DPP4i users Age % Male HbA1c % Hypertension % CVD % CKD
Solerte Multicenter, case control study Northern Italy 338 169 69 70 7.5 70 39 24
Mirani Single center, case series Milan (Italy) 90 11 71 72 NA 77 39 19
Rhee Healthcare insurance database Korea 832 263 62 54 NA 68 27 19
Yan Multicenter, case control study China 57 6 NA NA NA NA NA NA
Kim Multicenter, observational study South Korea 235 85 68 45 7.7 63 22 8
Chen Single center, observational Wuhan (China) 100 20 66 NA 7.9 33 21 12
Silverii Multicenter, observational study Sicily (Italy) 159 13 73 54 NA NA NA NA
Fadini Single center, case series North-East Italy 85 9 70 65 7.6 69 27 15
Cariou Multicenter, observational study France 1317 285 70 65 8.1 77 41 NA
Pérez-Belmonte Multicenter, observational study (with PSM) Spain 2666 (210 matched) 105 75 62 NA 76 23 13
Dalan Single center observartional study Singapore 76 27 NA NA NA NA NA NA
Nafakhi Single center observartional study Iraq 67 14 60 43 NA 66 15 NA
Overall 6022 1007 68 61 7.6 73 29 15

CVD cardiovascular disease; CKD chronic kidney disease, NA not available